About Curative Biotech
Curative Biotech is a company based in Boca Raton (United States) founded in 1995.. Curative Biotech offers products and services including Drug Pipeline, Therapeutic Assets, and Neuro Oncology Drugs. Curative Biotech operates in a competitive market with competitors including EyePoint Pharmaceuticals, Rezolute, Molecular Partners, Imvax and Aviceda Therapeutics, among others.
- Headquarter Boca Raton, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Curative Biotechnology Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-3.56 M9.91as on Dec 31, 2024
-
EBITDA
$-2.35 M-28as on Dec 31, 2024
-
Latest Funding Round
$146 K (USD), Post-IPO
Jan 17, 2023
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Curative Biotech
Curative Biotech is a publicly listed company on the OTC with ticker symbol CUBT in USA, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Curative Biotech
Curative Biotech offers a comprehensive portfolio of products and services, including Drug Pipeline, Therapeutic Assets, and Neuro Oncology Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops candidates for rare diseases like eye disorders
Targets infectious disease treatments through acquisition
Focuses on cancer-related drug candidates for rare indications
Funding Insights of Curative Biotech
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $146,000
-
First Round
First Round
(17 Jan 2023)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Post-IPO - Curative Biotech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Curative Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Curative Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Curative Biotech Comparisons
Competitors of Curative Biotech
Curative Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EyePoint Pharmaceuticals, Rezolute, Molecular Partners, Imvax and Aviceda Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics for ophthalmic disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for diseases are developed using DARPin technology.
|
|
| domain | founded_year | HQ Location |
Patient-specific cell vaccines for glioma treatment are developed.
|
|
| domain | founded_year | HQ Location |
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Gene therapy solutions for retinal diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Curative Biotech
Frequently Asked Questions about Curative Biotech
When was Curative Biotech founded?
Curative Biotech was founded in 1995 and raised its 1st funding round 28 years after it was founded.
Where is Curative Biotech located?
Curative Biotech is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
What does Curative Biotech do?
Curative Biotech was founded in 1995 in Boca Raton, United States, within the biotechnology sector. Focus is placed on developing therapeutic drugs targeting cancer, eye conditions, and infectious diseases. The pipeline includes candidates such as IMT504, an oligodeoxynucleotide for rabies treatment; CURB906, a fully humanized CD56 monoclonal antibody for brain tumors; and a reformulated metformin for degenerative eye disease. Operations center on drug candidate advancement for clinical applications.
Who are the top competitors of Curative Biotech?
Curative Biotech's top competitors include EyePoint Pharmaceuticals, Rezolute and Imvax.
What products or services does Curative Biotech offer?
Curative Biotech offers Drug Pipeline, Therapeutic Assets, and Neuro Oncology Drugs.
Is Curative Biotech publicly traded?
Yes, Curative Biotech is publicly traded on OTC under the ticker symbol CUBT.
What is Curative Biotech's ticker symbol?
The ticker symbol of Curative Biotech is CUBT on OTC.